New technologies aimed at percutaneous intervention in the small coronary artery

References

• Grüentzig A. Transluminal dilatation of coronary artery stenosis (letter). Lancet1, 263 (1978).
   PubMed Web of Science ®Google Scholar
• Serruys PW, DE Jaegere P, Kiemeneij F et al. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N. Engl. J. Med.331, 489–495 (1994).
   PubMed Web of Science ®Google Scholar
• Fischman DL, Leon MB, Baim DS et al. A randomised comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N. Engl. J. Med.331, 496–501 (1994).
   PubMed Web of Science ®Google Scholar
• Macaya C, Serruys PW, Ruygrok P et al. Continued benefit of coronary stenting versus balloon angioplasty: one year clinical follow up of Benestent Study Group. J. Am. Coll. Cardiol.27, 255–261 (1996).
   PubMed Web of Science ®Google Scholar
• Betriu A, Masotti M, Sera A et al. Randomised comparison of coronary stent implantation and balloon angioplasty in the treatment of de novo coronary artery lesions (START): a four-year follow-up. J. Am. Coll. Cardiol.34, 1498–1506 (1999).
   PubMed Web of Science ®Google Scholar
• Keimeneij F, Serruys PW, Macaya C et al. Continued benefit of coronary stenting versus balloon angioplasty: five-year clinical follow up of Benestent-I trial. J. Am. Coll. Cardiol.37, 1598–1603 (2001).
   PubMedGoogle Scholar
• Agostoni P, Biondi-Zoccai GG, Gasparini GL et al. Is bare-metal stenting superior to balloon angioplasty for small vessel coronary artery disease? Evidence from a meta-analysis of randomized trials. Eur. Heart J.26, 881–889 (2005).
   PubMed Web of Science ®Google Scholar
• Wong P, Lau KW, Lim YL, Oesterie SN. Stent placement for non-STRESS/BENESTENT lesions: a critical review. Catheter. Cardiovasc. Interv.51, 223–233 (2000).
   PubMedGoogle Scholar
• Doucet S, Schalij MJ, Vrolix MC et al. Stent placement to prevent restenosis after angioplasty in small coronary arteries. Circulation104, 2029–2033 (2001).
   PubMed Web of Science ®Google Scholar
• Biondi-Zoccai G, Moretti C, Abbate C, Sheiban I. Percutaneous coronary intervention for small vessel coronary artery disease. Cardiovasc. Revasc. Med.11, 189–198 (2010).
   PubMedGoogle Scholar
• Haude M, Konorza TF, Kalnins U et al. Heparin-coated stent placement for the treatment of stenoses in small coronary arteries of symptomatic patients. Circulation107, 1265–1270 (2003).
   PubMed Web of Science ®Google Scholar
• Colombo A, Chieffo A. Drug-eluting stent update 2007: part III: technique and unapproved/unsettled indications (left main, bifurcations, chronic total occlusions, small vessels and long lesions, saphenous vein grafts, acute myocardial infarctions, and multivessel disease). Circulation116, 1424–1432 (2007).
   PubMedGoogle Scholar
• Kucher N, Lipp E, Schwerzmann M, Zimmerli M, Allemann Y, Seiler C. Gender differences in coronary artery size per 100 g of left ventricular mass in a population without cardiac disease. Swiss Med. Wkly131, 610–615 (2001).
   PubMed Web of Science ®Google Scholar
• Kornowski R, Lansky AJ. Current perspectives on interventional treatment strategies in diabetic patients with coronary artery disease. Catheter. Cardiovasc. Interv.50, 245–254 (2000).
   PubMed Web of Science ®Google Scholar
• Abizaid AC, Costa JR Jr, Whitbourn RJ, Chang JC. The CardioMind coronary stent delivery system: stent delivery on a 0.014´´ guidewire platform. EuroIntervention3, 154–157 (2007).
   PubMedGoogle Scholar
• O’Connor NJ, Morton JR, Birmeyer JD, Olmstead EM, O’Connor GT. Northern New England Cardiovascular Disease Study Group. Effect of coronary artery diameter in patients undergoing coronary artery bypass surgery. Circulation93, 652–655 (1996).
   PubMedGoogle Scholar
• Kastrati A, Schömig A, Dirschinger J et al. A randomized trial comparing stenting with balloon angioplasty in small vessels in patients with symptomatic coronary artery disease: ISAR-SMART Study Investigators: Intracoronary Stenting or Angioplasty for Restenosis Reduction in Small Arteries. Circulation102, 2593–2598 (2000).
   PubMed Web of Science ®Google Scholar
• Mauri L, Orav EJ, Kuntz RE. Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison. Circulation111, 3435–3442 (2005).
   PubMed Web of Science ®Google Scholar
• Ellis SG, Popma JJ, Lasala JM et al. Relationship between angiographic late loss and target lesion revasculariation after coronary stent implantation: analysis from the TAXUS-IV trial. J. Am. Coll. Cardiol.45, 1193–1200 (2005).
   PubMed Web of Science ®Google Scholar
• Dussaillant GR, Mintz GS, Pichard AD et al. Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis. J. Am. Coll. Cardiol.26, 720–724 (1995).
   PubMed Web of Science ®Google Scholar
• Hirshfeld JW Jr, Schwartz JS, Jugo R et al. Restenosis after coronary angioplasty: a multivariate statistical model to relate lesion and procedural variables to restenosis. The M-HEART Investigators. J. Am. Coll. Cardiol.18, 647–656 (1991).
   PubMed Web of Science ®Google Scholar
• Kasoaka S, Tobis JM, Akiyama T et al. Angiographic and intravascular ultrasound predictors of in-stent restenosis. J. Am. Coll. Cardiol.32, 1630–1635 (1998).
   PubMed Web of Science ®Google Scholar
• Park SW, Lee CW, Hong ML et al. Randomized comparison of coronary stenting with optimal balloon angioplasty for treatment of lesions in small coronary arteries. Eur. Heart J.21, 1785–1789 (2000).
   PubMed Web of Science ®Google Scholar
• Koning R, Eltchaninoff H, Commeau P, Khalife K, Gilard M, Lipiecki J. Stent placement compared with balloon angioplasty for small coronary arteries: in-hospital and 6-month clinical and angiographic results. Circulation104, 1604–1608 (2001).
   PubMed Web of Science ®Google Scholar
• Garcia E, Gomez-Recio M, Moreno R et al. Stent reduces restenosis in small vessels. Results of the RAP study (abstract). J. Am. Coll. Cardiol.37, 17A (2001).
   Web of Science ®Google Scholar
• Muramatsu T, Iwasaki K, Inou N, Horita Y, Tanaka T, Fujita N. Efficacy of coronary stenting versus balloon angioplasty in vessels of diameters less than 3.0 mm and less than 2.5 mm: CHIVAS Investigators (abstract). Am. J. Cardiol.90, 96H (2002).
   Google Scholar
• Moer R, Myreng Y, Molstad P et al. Stenting in small coronary arteries (SISCA) trial. A randomized comparison between balloon angioplasty and the heparin-coated beStent. J. Am. Coll. Cardiol.38, 1598–1603 (2001).
   PubMed Web of Science ®Google Scholar
• Kinsara AJ, Niazi K, Patel I, Amoudi O. Effectiveness of stents in small coronary arteries. Am. J. Cardiol.92, 584–587 (2003).
   PubMedGoogle Scholar
• Hanekamp C, Koolen J, Bonnier H et al. Randomized comparison of balloon angioplasty versus silicon carbon-coated stent implantation for de novo lesions in small coronary arteries. Am. J. Cardiol.93, 1233–1237 (2004).
   PubMed Web of Science ®Google Scholar
• Hausleiter J, Kastrati A, Mehilli J et al. A randomized trial comparing phosphorylcholine-coated stents with balloon angioplasty in small coronary arteries in patients with symptomatic coronary artery disease. The ISAR-SMART 2 trial (abstract). Circulation108, IV-569 (2003).
   Google Scholar
• Rodriguez AE, Rodriguez Alemparte MJ, Pereira CF et al. Final angiographic and clinical results of the Latin America small vessel randomized study (LASMAL trial) (abstract). J. Am. Coll. Cardiol.41(6 Suppl. 1), 26 (2003).
   PubMedGoogle Scholar
• Rodriguez AE, Rodriguez Alemparte M, Fernandez Pereira C et al. Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] trial): immediate and long-term results. Am. Heart J.150, 188 (2005).
   PubMedGoogle Scholar
• Greenhalgh J, Hockenhull J, Rao N, Dundar Y, Dickson RC, Bagust A. Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes. Cochrane Database Syst. Rev.12, CD004587 (2010).
   Google Scholar
• Ardissino D, Cavallini C, Bramucci E et al. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries. JAMA292, 2727–2734 (2004).
   PubMed Web of Science ®Google Scholar
• Holmes DR Jr, Leon MB, Moses JW et al. Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomised trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation109, 634–640 (2004).
   PubMed Web of Science ®Google Scholar
• Stone GW, Ellis SG, Cox DA et al. One-year clinical results with the slow-release, polymer based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation109, 1942–1947 (2004).
   PubMed Web of Science ®Google Scholar
• Stone GW, Ellis SG, Canon L et al. Comparison of a polymner-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomised controlled trial. JAMA294, 1215–1223 (2005).
   PubMed Web of Science ®Google Scholar
• Dawkins KD, Grube E, Guagliumi G et al. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomised trial: support for the use of drug-eluting stents in contemporary clinical practice. Circulation112, 3306–3313 (2005).
   PubMed Web of Science ®Google Scholar
• Grube E, Dawkins KD, Guagliumi G et al. TAXUS VI 2-year follow-up: randomized comparison of polymer-based paclitaxel-eluting with bare metal stents for treatment of long, complex lesions. Eur. Heart J.28, 2578–2582 (2007).
   PubMed Web of Science ®Google Scholar
• Fajadet J, Wijns W, Larrman GJ et al. Randomised, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphoryl-choline-encapsulated stent for the treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II Trial. Circulation114, 798–806 (2006).
   PubMed Web of Science ®Google Scholar
• Morice MC, Colombo A, Meier B et al. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. JAMA295, 895–904 (2006).
   PubMed Web of Science ®Google Scholar
• Mehilli J, Dibra A, Kastrati A, Pache J, Dirschinger J, Schomig A. Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels. Eur. Heart J.27, 260–266 (2006).
   PubMed Web of Science ®Google Scholar
• Togni M, Eber S, Widmer J et al. Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a sub-group analysis of the SIRTAX Trial. J. Am. Coll. Cardiol.50, 1123–1131 (2007).
   PubMedGoogle Scholar
• Rodriguez-Granillo GA, Valgimigli M, Garcia-Garcia HM et al. One-year clinical outcome after coronary stenting of very small vessels using 2.25 mm sirolimus- and paclitaxel-eluting stents: a comparison between the RESEARCH and T-SEARCH registries. J. Invasive Cardiol.17, 409–412 (2005).
   PubMedGoogle Scholar
• Stone GW, Rizve A, Newman W et al. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. N. Engl. J. Med.162, 1663–1664 (2010).
   Google Scholar
• Leon MB, Mauri L, Popma JJ et al. A randomised comparison of the ENDEAVOR zotrolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions: 12 month outcomes from the ENDEAVOR IV trial. J. Am. Coll. Cardiol.55, 543–554 (2010).
   PubMed Web of Science ®Google Scholar
• Byrne R. Biodegradable polymer versus durable polymer drug-eluting stents for patients with coronary artery disease: 3 years pooled data from the ISAR-TEST 4, LEADERS and ISAR-TEST 3 randomized trials. Presented at: Late Breaking Registries and Trial Updates Session. Orlando, FL, USA, 20 May 2011.
   Google Scholar
• Windecker S, Serruys PW, Wandel S et al. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularization (LEADERS): a randomised non-inferiority trial. Lancet372, 1163–1173 (2008).
   PubMed Web of Science ®Google Scholar
• Mehilli J, Byren RA, Wieczorek A et al. Randomized trial of three rapamycin-eluting stents with different coating strategies for reduction of coronary restenosis. Eur. Heart J.29, 1975–1982 (2008).
   PubMed Web of Science ®Google Scholar
• Byrne RA, Kastrati A, Kufner S et al. Randomized, non-inferiority trial of three limus agent-eluting stents with different polymenr coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST 4) trial. Eur. Heart J.30, 2441–2449 (2009).
   PubMed Web of Science ®Google Scholar
• Wykrzykowska JJ, Serruys PW, Onuma Y et al. Impact of vessel size on angiographic and clinical outcomes of revascularization with biolimus-eluting stent with biodegradable polymer and sirolimus-eluting stent with durable polymer the LEADERS trial substudy. J. Am. Coll. Cardiol.2, 861–870 (2009).
   Google Scholar
• Rathore S. Small coronary vessel angioplasty: outcomes and technical considerations. Vasc. Health Risk Manag.6, 915–922 (2010).
   PubMedGoogle Scholar
• Banning AP, Lim CC. Drug-eluting balloons: what is their place on the interventionalist’s shelf? Heart96, 1257–1258 (2010).
   PubMedGoogle Scholar
• Elezi S, Kastrati A, Neumann FJ, Hadamitzky M, Dirschinger J, Schomig A. Vessel size and long-term outcome after coronary stent placement. Circulation98, 1875–1880 (1998).
   PubMed Web of Science ®Google Scholar
• Bauters C, Hubert E, Prat A et al. Predictors of restenosis after coronary stent implantation. J. Am. Coll. Cardiol.31, 1291–1298 (1998).
   PubMed Web of Science ®Google Scholar
• Kastrati A, Dibra A, Mehilli J et al. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents. Circulation113, 2293–2300 (2006).
   PubMed Web of Science ®Google Scholar
• Lee CW, Suh J, Lee SW et al. Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries. Catheter. Cardiovasc. Interv.69, 821–825 (2007).
   PubMedGoogle Scholar
• Pfisterer M, Brunner-La HP, Rickenbacher P et al. Long-term benefit-risk balance of drug-eluting vs. bare–metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET. Eur. Heart J.30, 16–24 (2009).
   PubMed Web of Science ®Google Scholar
• Menozzi A, Solinas E, Ortolani P et al. Twenty-four months clinical outcome of sirolimus-eluting stents for the treatment of small coronary arteries: the long-term SES-SMART clinical study. Eur. Heart J.30, 2095–2101 (2009).
   PubMed Web of Science ®Google Scholar
• Birkmeier KA, Kastrati A, Byrne RA et al. Five-year clinical outcomes of sirolimus-eluting versus paclitaxel-eluting stents in high-risk patients. Catheter. Cardiovasc. Interv.77, 494–501 (2011).
   PubMed Web of Science ®Google Scholar
• Granada JF, Pomeranz M, Heringes J et al. vProtect™ luminal shield system. EuroIntervention3, 416–419 (2007).
   PubMedGoogle Scholar
• Briguori C, Sarais C, Pagnotta P et al. In-stent restenosis in small coronary arteries: impact of strut thickness. J. Am. Coll. Cardiol.40, 403–409 (2002).
   PubMed Web of Science ®Google Scholar
• Kastrati A, Mehilli J, Dirschinger J et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO trial). Circulation103, 2816–2821 (2001).
   PubMed Web of Science ®Google Scholar
• Pache J, Kastrati A, Mehilli J et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. J. Am. Coll. Cardiol.41, 1283–1288 (2003).
   PubMed Web of Science ®Google Scholar
• Turco MA, Ormiston JA, Popma JJ et al. Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut TAXUS Liberte stent: 1-year results from the TAXUS ATLAS program. JACC Cardiovasc. Interv.1, 699–709 (2008).
   PubMedGoogle Scholar
• Cannon LA, Simon DI, Kereiakes D et al. The XIENCE nano™ everolimus eluting coronary stent system for the treatment of small coronary arteries: the SPIRIT small vessel trial. Catheter Cardiovasc. Interv. doi:10.1002/ccd.23397 (2011) (Epub ahead of print).
   Google Scholar
• Jabara R, Geva S, Ribeiro HB et al. A third generation ultra-thin strut cobalt chromium stent: histopathological evaluation in porcine coronary arteries. EuroIntervention5, 619–626 (2009).
   PubMedGoogle Scholar
• Scheller B, Speck U, Schmitt A, Böhm M, Nickenig G. Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. J. Am. Coll. Cardiol.42, 1415–1420 (2003).
   PubMed Web of Science ®Google Scholar
• Scheller B, Speck U, Romeike B et al. Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. Eur. Heart J.24, 1462–1467 (2003).
   PubMed Web of Science ®Google Scholar
• Herdeg C, Göhring-Frischholz K, Haase KK et al. Catheter-based delivery of fluid paclitaxel for prevention of restenosis in native coronary artery lesions after stent implantation. Circ. Cardiovasc. Interv.2, 294–301 (2009).
   PubMed Web of Science ®Google Scholar
• Scheller B, Speck U, Abramjuk C, Bernhardt U, Böhm M, Nickenig G. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation110, 810–814 (2004).
   PubMed Web of Science ®Google Scholar
• Axel DI, Kunert W, Goggelmann C et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation96, 636–645 (1997).
   PubMed Web of Science ®Google Scholar
• Speck U, Scheller B, Abramjuk C et al. Neointima inhibition: comparison of effectiveness of non-stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries. Radiology240, 411–418 (2006).
   PubMed Web of Science ®Google Scholar
• Cortese B, Micheli A, Picchi A et al. Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO Study. Heart96, 1291–1296 (2010).
   PubMed Web of Science ®Google Scholar
• Scheller B, Hehrlein C, Bocksch W et al. Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. Clin. Res. Cardiol.97, 773–781 (2008).
   PubMed Web of Science ®Google Scholar
• Unverdorben M, Vallbracht C, Cremers B et al. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation119, 2986–2994 (2009).
   PubMed Web of Science ®Google Scholar
• Unverdorben M, Kleber FX, Heuer H et al. Treatment of small coronary arteries with a paclitaxel-coated balloon catheter. Clin. Res. Cardiol.99, 165–174 (2010).
   PubMed Web of Science ®Google Scholar
• Zeymer U, Scheller B. PCI in small vessels: the case for a drug-coated balloon based intervention. EuroIntervention7(Suppl. K), K57–K60 (2011).
   PubMedGoogle Scholar
• Vaquerizo Montilla B, Serra A, Miranda-Guardiola F et al. Mid-term results of a new paclitaxel eluting balloon for the treatment of complex coronary lesions: insights from the Dior Spanish Multicenter Registry. Eur. Heart J.31(Suppl. 1), 355–356 (2010).
   Google Scholar
• Shand JA, Kodoth V, Menown IBA. Novel stent and drug elution technologies. Interv. Cardiol.3, 473–481 (2011).
   Google Scholar
• Cremers B, Biedermann M, Mahnkopf D, Böhm M, Scheller B. Comparison of two different paclitaxel-coated balloon catheters in the porcine coronary restenosis model. Clin. Res. Cardiol.98, 325–330 (2009).
   PubMed Web of Science ®Google Scholar
• Radke PW, Joner M, Joost A et al. Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipients. EuroIntervention7, 730–737 (2011).
   PubMed Web of Science ®Google Scholar
• Elezi S, Dibra A, Mehilli J et al. Vessel size and outcome after coronary drug-eluting stent placement: results from a large cohort of patients treated with sirolimus- or paclitaxel-eluting stents. J. Am. Coll. Cardiol.48, 1304–1309 (2006).
   PubMedGoogle Scholar
• Schnorr B, Speck U, Scheller B. Review of clinical data with Paccocath – coated balloon catheters. Minerva Cardioangiol.59, 431–435 (2011).
   PubMedGoogle Scholar
• Gutiérrez-Chico JL, van Geuns RJ et al. Paclitaxel-coated balloon in combination with bare metal stent for treatment of de novo coronary lesions: an optical coherence tomography first-in-human randomised trial, balloon first vs. stent first. Eurointervention7, 711–722 (2011).
   PubMed Web of Science ®Google Scholar
• Pöss J, Jacobshagen C, Ukena C, Böhm M. Hotlines and clinical trial updates presented at the German Cardiac Society Meeting 2010: FAIR-HF, CIPAMI, LIPSIA-NSTEMI, Handheld-BNP, PEPCAD III, remote ischaemic conditioning, CERTIFY, PreSCD-II, German Myocardial Infarction Registry, DiaRegis. Clin. Res. Cardiol.99, 411–417 (2010).
   PubMed Web of Science ®Google Scholar
• Wijns W, Kolh P, Danchin N et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J.31, 2501–2555 (2010).
   PubMed Web of Science ®Google Scholar
• Stella PR, Belkacemi A, Waksman R et al. The Valentines trial: results of the first one week worldwide multicentre enrolment trial, evaluating the real world usage of the second generation DIOR paclitaxel drug-eluting balloon for in-stent restenosis treatment. EuroIntervention7, 705–710 (2011).
   PubMedGoogle Scholar
• Cortese B, Bertoletti A. Paclitaxel coated balloons for coronary artery interventions: a comprehensive review of preclinical and clinical data. Int. J. Cardiol. doi:org/10.1016/j.ijcard.2011.08.855 (2011) (Epub ahead of print).
   Google Scholar
• Wöhrle J, Birkemeyer R, Markovic S T et al. Prospective randomised trial evaluating a paclitaxel-coated balloon in patients treated with endothelial progenitor cell capturing stents for de novo coronary artery disease. Heart97, 1338–1342 (2011).
   PubMed Web of Science ®Google Scholar
• Duckers HJ, Silber S, de Winter R et al. Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the HEALING-II trial: evaluation of an endothelial progenitor cell capturing stent. EuroIntervention3, 67–75 (2007).
   PubMedGoogle Scholar
• Klomp M, Beijk MA, Varma C et al. 1-year outcome of TRIAS HR (TRI-stent Adjudication Study-High Risk of Restenosis) a multicenter, randomized trial comparing Genous endothelial progenitor cell capturing stents with drug-eluting stent. JACC Cardiovasc. Interv.4, 896–904 (2011).
   PubMed Web of Science ®Google Scholar
• Silber S, Damman P, Klomp M et al. Clinical results after coronary stenting with the Genous™ bio-engineered R Stent™: 12-month outcomes of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry. EuroIntervention6, 819–825 (2011).
   PubMed Web of Science ®Google Scholar
• Costa JR Jr, Abizaid A. Svelte Acrobat Stent-On-A-Wire coronary stent system. Eur. Cardiol.6, 36–39 (2010).
   Google Scholar
• Hamon M, Richardeau Y, Lecluse E et al. Direct coronary stenting without balloon predilation in acute coronary syndromes. Am. Heart J.138, 55–59 (1999).
   PubMed Web of Science ®Google Scholar
• Pentousis D, Guerin Y, Funck F et al. Direct stent implantation without predilatation using the MultiLink stent. Am. J. Cardiol.82, 1437–1440 (1998).
   PubMedGoogle Scholar
• Laarman G, Muthusamy TS, Swart H et al. Direct coronary stent implantation: safety, feasibility, and predictors of success of the strategy of direct coronary stent implantation. Catheter. Cardiovasc. Interv.52, 443–448 (2001).
   PubMedGoogle Scholar
• Sabatier R, Hamon M, Zhao QM et al. Could direct stenting reduce no-reflow in acute coronary syndromes? A randomized pilot study. Am. Heart J.143, 1027–1032 (2002).
   PubMedGoogle Scholar
• Gasior M, Gierlotka M, Lekston A et al. Comparison of outcomes of direct stenting versus stenting after balloon predilation in patients with acute myocardial infarction (DIRAMI). Am. J. Cardiol.100, 798–805 (2007).
   PubMed Web of Science ®Google Scholar
• Ormiston JA, Mahmud E, Turco MA et al. Direct stenting with the TAXUS Liberte drug-eluting stent. JACC Cardiol. Interv.1, 150–160 (2008).
   PubMed Web of Science ®Google Scholar
• Wilson SH, Berger PB, Mathew V et al. Immediate and late outcomes after direct stent implantation without balloon predilation. J. Am. Coll. Cardiol.35, 937–943 (2000).
   PubMed Web of Science ®Google Scholar
• Briguori C, Sheiban I, De Gregorio J et al. Direct coronary stenting without predilation. J. Am. Coll. Cardiol.34, 1910–1915 (1999).
   PubMedGoogle Scholar
• Serruys PW, Ijsselmuiden S, Hout B et al. Direct stenting with the Bx VELOCITY balloon-expandable stent mounted on the Raptor rapid exchange delivery system versus predilatation in a European randomized Trial: the VELVET trial. Int. J. Cardiovasc. Interv.5, 17–26 (2003).
   PubMedGoogle Scholar
• Fischell TA. A new fixed-wire, ‘stent-on-a-wire’, very-low-profile stent delivery system – rationale, design and update. Interv. Cardiol.5, 20–22 (2010).
   Google Scholar
• Sarno G, Okamura T, Gomez-Lara J et al. The coronary Stent-On-A-Wire (SOAW). EuroIntervention6, 413–417 (2010).
   PubMed Web of Science ®Google Scholar
• Shin ES, Garcia-Garcia HM, Okamura T et al. Comparison of acute vessel wall injury after self-expanding stent and conventional balloon-expandable stent implantation: a study with optical coherence tomography. J. Invasive Cardiol.22, 435–439 (2010).
   PubMedGoogle Scholar
• Abizaid AC, Botelho R, Verheye S et al. Care II 8 month follow-up results with the CardioMind® 0.014´´ Sparrow® sirolimus-eluting nitinol stent system. J. Am. Coll. Cardiol.56, B53 (2010).
   Web of Science ®Google Scholar
• Chamié D, Costa JR Jr, Abizaid A et al. Serial angiography and intravascular ultrasound: results of the SISC Registry (Stents In Small Coronaries). JACC Cardiol. Interv.3, 191–202 (2010).
   PubMed Web of Science ®Google Scholar
• Waksman R, Erbel R, Di Mario C et al. Early- and long-term intravascular ultrasound and angiographic findings after bioabsorbable magnesium stent implantation in human coronary arteries. J. Am. Coll. Cardiol.2, 312–320 (2009).
   Google Scholar
• Serruys PW, Ormiston JA, Onuma Y et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet373, 897–910 (2009).
   PubMed Web of Science ®Google Scholar
• Onuma Y, Serruys PW, Ormiston JA et al. Three-year results of clinical follow-up after bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial. EuroIntervention6, 447–453 (2010).
   PubMed Web of Science ®Google Scholar
• Diletti R, Onuma Y, Faroog V et al. 6-month clinical outcomes following implantation of the bioresorbable everolimus-eluting vascular scaffold in vessels smaller or larger than 2.5 mm. J. Am. Coll. Cardiol.58, 258–264 (2011).
   PubMed Web of Science ®Google Scholar
• Tsuchikane E, Takeda Y, Kobuyashi Y, Nishibe A, Kobuyoshi T, Awata N. Which is better for small coronary artery disease, stenting or balloon angioplasty plus cilostazol? From results of COMPASS. Circulation106, II482 (2002).
   Google Scholar
• Gray WA, Granada JF. Drug-coated balloons for the prevention of vascular restenosis. Circulation121, 2672–2680 (2010).
   PubMed Web of Science ®Google Scholar